Hosts
Top Stories from CNBC- U.S. Steel plans to lay off hundreds of workers in Michigan
- China lowers borrowing costs — but UBS says the impact will probably be 'very muted'
- Porsche to stream Apple Music into all-new Taycan EV
- Apple is spending $6 billion on original shows and trying to beat Disney+ to market, reports FT
- A generational shift in consumer tastes is a boon for these retailers, Jim Cramer says
Mergers & Acquisitions
Billionaire investor Carl Icahn believes Occidental’s acquisition of Anadarko is the worst tie-up he’s seen in his long career on Wall Street.
Pfizer will be merging with its off patent business with Mylan creating a new company that controls a number of blockbuster medicines. Meg Tirrell has more for us on this mega deal.
Pfizer, the world’s largest drugmaker, plans to divest its off-patent drug business and combine it with generic-drug maker Mylan.
With the $26 billion merger between Sprint and T-Mobile, this could bring a new era for the wireless carrier industry. Joining us to discuss this topic is Jonathan Chaplin, who’s the Managing Partner at New Street Research.
Sprint and T-Mobile’s $26 billion deal gets the Department of Justice’s approval but there are some conditions. Ylan Mui reports.
The Department of Justice has formally announced an agreement on the more than $26 billion merger between T-Mobile and Sprint.
Symantec and Broadcom have ceased deal negotiations, sources tell CNBC’s David Faber. The people familiar with the matter added that Symantec would not accept less than $28 a share.
CNBC is reporting Broadcom is in talks to acquire Symantec which is a company that makes cybersecurity software for the enterprise and consumer. Josh Lipton breaks down Broadcom’s playbook in buying companies and then building a portfolio of products.
Dish and T-Mobile are near a deal with the DOJ on a hosting agreement that would prop up Dish as a new fourth U.S. wireless competitor, sources say.
Abbvie offers to buy Allergan for $63 billion dollars as big drug makers look for new ways to grow. Meg Tirrell reports.
Pfizer makes a $10 billion deal to expand its cancer lineup and its footprint in an area as known as a precision medicine. Meg Tirrell reports.
Soon after the mega deal between United Technologies & Raytheon, questions were swirling. Morgan Brennan explains.
Legal action may be brought to CVS on their recent $69 billion acquisition of Aetna. A federal judge could reportedly block the deal. Bertha Coombs has more for us.
United Technologies & Raytheon are merging to create an aerospace powerhouse that the company say will redefine the defense industry. Morgan Brennan has more for us at the New York Stock Exchange.
Wall Street continued its winning streak on Monday as the Dow reclaimed to the 26,000 plateau. What caused these lifts on the stock market? Bob Pisani has more for us at the New York Stock Exchange.
